Radiation Oncology: A subspecialty of medical oncology and radiology concerned with the radiotherapy of cancer.Health Physics: The science concerned with problems of radiation protection relevant to reducing or preventing radiation exposure, and the effects of ionizing radiation on humans and their environment.Medical Oncology: A subspecialty of internal medicine concerned with the study of neoplasms.Radiation Injuries: Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in VERTEBRATES.Radiotherapy: The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions.Cancer Care Facilities: Institutions specializing in the care of cancer patients.Radiobiology: Study of the scientific principles, mechanisms, and effects of the interaction of ionizing radiation with living matter. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)Radiotherapy, Computer-Assisted: Computer systems or programs used in accurate computations for providing radiation dosage treatment to patients.Brachytherapy: A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues.Radiotherapy Dosage: The total amount of radiation absorbed by tissues as a result of radiotherapy.Radiation Dosage: The amount of radiation energy that is deposited in a unit mass of material, such as tissues of plants or animal. In RADIOTHERAPY, radiation dosage is expressed in gray units (Gy). In RADIOLOGIC HEALTH, the dosage is expressed by the product of absorbed dose (Gy) and quality factor (a function of linear energy transfer), and is called radiation dose equivalent in sievert units (Sv).Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.Radiation, Ionizing: ELECTROMAGNETIC RADIATION or particle radiation (high energy ELEMENTARY PARTICLES) capable of directly or indirectly producing IONS in its passage through matter. The wavelengths of ionizing electromagnetic radiation are equal to or smaller than those of short (far) ultraviolet radiation and include gamma and X-rays.Societies, Medical: Societies whose membership is limited to physicians.Radiotherapy Planning, Computer-Assisted: Computer-assisted mathematical calculations of beam angles, intensities of radiation, and duration of irradiation in radiotherapy.Dose-Response Relationship, Radiation: The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation.Radiotherapy, Conformal: Radiotherapy where there is improved dose homogeneity within the tumor and reduced dosage to uninvolved structures. The precise shaping of dose distribution is achieved via the use of computer-controlled multileaf collimators.Oncology Nursing: A nursing specialty concerned with the care provided to cancer patients. It includes aspects of family functioning through education of both patient and family.Radiation Tolerance: The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS.Radiotherapy, Image-Guided: The use of pre-treatment imaging modalities to position the patient, delineate the target, and align the beam of radiation to achieve optimal accuracy and reduce radiation damage to surrounding non-target tissues.Radiotherapy, High-Energy: Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle.Dose Fractionation: Administration of the total dose of radiation (RADIATION DOSAGE) in parts, at timed intervals.Radiology Department, Hospital: Hospital department which is responsible for the administration and provision of x-ray diagnostic and therapeutic services.Radiotherapy, Intensity-Modulated: CONFORMAL RADIOTHERAPY that combines several intensity-modulated beams to provide improved dose homogeneity and highly conformal dose distributions.Combined Modality Therapy: The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.Radiation: Emission or propagation of acoustic waves (SOUND), ELECTROMAGNETIC ENERGY waves (such as LIGHT; RADIO WAVES; GAMMA RAYS; or X-RAYS), or a stream of subatomic particles (such as ELECTRONS; NEUTRONS; PROTONS; or ALPHA PARTICLES).Radiation ProtectionQuality Assurance, Health Care: Activities and programs intended to assure or improve the quality of care in either a defined medical setting or a program. The concept includes the assessment or evaluation of the quality of care; identification of problems or shortcomings in the delivery of care; designing activities to overcome these deficiencies; and follow-up monitoring to ensure effectiveness of corrective steps.Radiation Monitoring: The observation, either continuously or at intervals, of the levels of radiation in a given area, generally for the purpose of assuring that they have not exceeded prescribed amounts or, in case of radiation already present in the area, assuring that the levels have returned to those meeting acceptable safety standards.Radiosurgery: A radiological stereotactic technique developed for cutting or destroying tissue by high doses of radiation in place of surgical incisions. It was originally developed for neurosurgery on structures in the brain and its use gradually spread to radiation surgery on extracranial structures as well. The usual rigid needles or probes of stereotactic surgery are replaced with beams of ionizing radiation directed toward a target so as to achieve local tissue destruction.Radiotherapy, Adjuvant: Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.Oncology Service, Hospital: The hospital department responsible for the administration and provision of diagnostic and therapeutic services for the cancer patient.Chemoradiotherapy: Treatment that combines chemotherapy with radiotherapy.Accreditation: Certification as complying with a standard set by non-governmental organizations, applied for by institutions, programs, and facilities on a voluntary basis.Health Planning: Planning for needed health and/or welfare services and facilities.Positron-Emission Tomography: An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower.Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Neoplasm Staging: Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.Forecasting: The prediction or projection of the nature of future problems or existing conditions based upon the extrapolation or interpretation of existing scientific data or by the application of scientific methodology.Head and Neck Neoplasms: Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.Tomography, X-Ray Computed: Tomography using x-ray transmission and a computer algorithm to reconstruct the image.Breast Neoplasms: Tumors or cancer of the human BREAST.United StatesCosmic Radiation: High-energy radiation or particles from extraterrestrial space that strike the earth, its atmosphere, or spacecraft and may create secondary radiation as a result of collisions with the atmosphere or spacecraft.Retrospective Studies: Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.Neoplasm Recurrence, Local: The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.Radiation Injuries, Experimental: Experimentally produced harmful effects of ionizing or non-ionizing RADIATION in CHORDATA animals.Radiation Pneumonitis: Inflammation of the lung due to harmful effects of ionizing or non-ionizing radiation.Prognosis: A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.Physician's Practice Patterns: Patterns of practice related to diagnosis and treatment as especially influenced by cost of the service requested and provided.Survival Rate: The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.Prostatic Neoplasms: Tumors or cancer of the PROSTATE.Neoplasms, Radiation-Induced: Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation.Japan

Intensity modulated radiation therapy (IMRT): a new promising technology in radiation oncology. (1/250)

Intensity modulated radiation therapy (IMRT) is a new technology in radiation oncology that delivers radiation more precisely to the tumor while relatively sparing the surrounding normal tissues. It also introduces new concepts of inverse planning and computer-controlled radiation deposition and normal tissue avoidance in contrast to the conventional trial-and-error approach. IMRT has wide application in most aspects of radiation oncology because of its ability to create multiple targets and multiple avoidance structures, to treat different targets simultaneously to different doses as well as to weight targets and avoidance structures according to their importance. By delivering radiation with greater precision, IMRT has been shown to minimize acute treatment-related morbidity, making dose escalation feasible which may ultimately improve local tumor control. IMRT has also introduced a new accelerated fractionation scheme known as SMART (simultaneous modulated accelerated radiation therapy) boost. By shortening the overall treatment time, SMART boost has the potential of improving tumor control in addition to offering patient convenience and cost savings.  (+info)

Communication between primary care physicians and radiation oncologists regarding patients with cancer treated with palliative radiotherapy. (2/250)

PURPOSE: The purpose of this study was to assess the satisfaction and information needs of primary care physicians (PCPs) regarding communication with radiation oncologists (ROs), with respect to patients who receive palliative radiotherapy (RT). A selected objective was to evaluate the agreement between PCPs' expectations and the content of the RO letter sent after completion of RT. PCPs' knowledge of the role of palliative RT and their awareness of available patient support services were also determined. METHODS: The PCPs of patients discharged from the Cross Cancer Institute after receiving palliative RT were surveyed using a mail-out questionnaire. Questions regarding communication, RT knowledge, and awareness of support services were asked. The corresponding RO letter was reviewed. RESULTS: A total of 148 PCPs were identified and were mailed questionnaires, with 114 (77%) responding. Overall, 80% (87 of 109) of PCPs found the RO letter to be useful in patient management. However, there was poor (< 53%) agreement between PCPs' expectations and the actual content of the RO letter. Knowledge of the indications and effectiveness of palliative RT was limited, with PCPs obtaining a median score of 4 of a possible 8. Only 27% (31 of 114) of PCPs were aware of all five of the patient support services listed. CONCLUSION: Results show that although the majority of PCPs found the RO letter useful, they believed that the letter lacked important information while containing unnecessary details. Communication between PCPs and ROs needs improvement, especially considering that PCPs seem to have limited knowledge of palliative RT.  (+info)

Waiting lists for radiation therapy: a case study. (3/250)

BACKGROUND: Why waiting lists arise and how to address them remains unclear, and an improved understanding of these waiting list "dynamics" could lead to better management. The purpose of this study is to understand how the current shortage in radiation therapy in Ontario developed; the implications of prolonged waits; who is held accountable for managing such delays; and short, intermediate, and long-term solutions. METHODS: A case study of the radiation therapy shortage in 1998-99 at Princess Margaret Hospital, Toronto, Ontario, Canada. Relevant documents were collected; semi-structured, face-to-face interviews with ten administrators, health care workers, and patients were conducted, audio-taped and transcribed; and relevant meetings were observed. RESULTS: The radiation therapy shortage arose from a complex interplay of factors including: rising cancer incidence rates; broadening indications for radiation therapy; human resources management issues; government funding decisions; and responsiveness to previous planning recommendations. Implications of delays include poorer cancer control rates; patient suffering; and strained doctor-patient relationships. An incompatible relationship exists between moral responsibility, borne by government, and legal liability, borne by physicians. Short-term solutions include re-referral to centers with available resources; long-term solutions include training and recruiting health care workers, improving workload standards, increasing compensation, and making changes to the funding formula. CONCLUSION: Human resource planning plays a critical role in the causes and solutions of waiting lists. Waiting lists have harsh implications for patients. Accountability relationships require realignment.  (+info)

Assessing portal design skills in the radiation oncology interactive case management examination. (4/250)

The American Board of Radiology is developing a computerized interactive case management examination to be used to evaluate the clinical skills of radiation oncologists. In the past, these skills have been evaluated by a pencil and paper written examination and an oral examination. With the increasing capabilities of computers, these skills can be easily, and perhaps even better, evaluated digitally. The aim is to develop an examination, which will be based on actual clinical cases, and be interactive so that it better mimics the clinical practice of a radiation oncologist than a written examination. It will also be less labor-intensive and less expensive than an oral examination. One of the most important skills of a radiation oncologist is the ability to design treatment portals that will encompass the entire cancer and yet minimize the irradiation of critical tissues and normal organs. Important parameters for radiation oncologists include the direction of the treatment beam, the size and shape of the portals, and the location of the margins of the field relative to patient anatomy and tumor location. In order to evaluate a physician's ability to design treatment portals, the computer-based examination has the capability to interactively construct field lines. The computer interface allows the candidate to draw field lines on a digitized x-ray image in a manner similar to practice. After the candidate illustrates the field lines, the evaluation of the response must be performed quickly to avoid interrupting the flow of the examination. The answer key is stored as a lossless compressed image. The key contains three regions consisting of (1) the must include region, which contains the tumor; (2) the must-exclude region, which contains tissues that if damaged would affect patient vitality and quality of life; and (3) the envelope of acceptable curves. Each region is assigned a unique byte code. The candidate's response is assigned a fourth byte code. Using basic logic operations, the response is swiftly evaluated. The scoring algorithm scores a candidate's action as correct if his/her drawn area encompasses all of the "must-include region" and is within the "envelope of acceptable curves." It scores a candidate's action as incorrect if his/her drawn area overlaps any part of the "exclude region" and/or exceeds at any point the "envelope of acceptable curves."  (+info)

Variation in delivery of palliative radiotherapy to persons dying of cancer in nova scotia, 1994 to 1998. (5/250)

PURPOSE: To examine sociodemographic and clinical variables associated with provision of palliative radiotherapy (RT) to persons dying of cancer. METHODS: The Nova Scotia Cancer Registry was used to identify 9,978 adults who were dying of cancer between 1994 and 1998 in the Canadian province of Nova Scotia. RT records from between April 1992 and December 1998 were obtained from the provincial treatment database. Multivariate analysis identified factors associated with two sequential decisions determining provision of palliative RT in the last 9 months of life: likelihood of receiving an RT consultation with a radiation oncologist and, given a consultation, likelihood of being treated with palliative RT. RESULTS: The likelihood of having a consultation decreased with age (20 to 59 years v. 80+ years: odds ratio [OR], 4.43 [95% confidence interval, 3.80 to 5.15]), increased with community median household income (> $50,000 v. < $20,000: OR, 1.31 [1.02 to 1.70]), was higher for residents closer to the cancer center (< 25 km v 200+ km: OR, 2.47 [2.16 to 2.83]), increased between 1994 and 1998 (OR, 1.34 [1.16 to 1.56]), varied by cause of death (relative to thoracic cancers, head and neck: OR, 1.75 [1.31 to 2.33]; gynecologic: OR, 0.35 [0.27 to 0.44]), and was greater for those who had prior RT (OR, 2.20 [1.89 to 2.56]). Similar associations were observed when outcome was the provision of palliative RT given a consult, with one notable exception: prior RT was associated with a lower likelihood of receiving palliative RT (OR, 0.48 [0.40 to 0.58]). CONCLUSION: Variations observed in delivery of palliative RT should prompt further investigation into equity of access to clinically appropriate, palliative radiation consultation and treatment.  (+info)

Cancer physicians' attitudes toward colorectal cancer follow-up. (6/250)

BACKGROUND: The optimal follow-up strategy for colorectal cancer is unknown. MATERIALS AND METHODS: We surveyed all Canadian radiation oncologists, medical oncologists and surgeons specializing in colorectal cancer to assess their recommendations for follow-up after potentially curative treatment, the beliefs and attitudes underlying these practices, and the cost implications of different follow-up strategies. RESULTS: One hundred and sixty practitioners (58%) returned completed surveys. Most recommended clinical assessments every 3-4 months in the first 2 years including carcino-embryonic antigen testing, gradually decreasing in frequency over 5 years. Ninety per cent recommend a surveillance colonoscopy in the first year. The majority felt that specialist involvement in follow-up was important because of the increased opportunities for patients to contribute to research (76%) and teaching (73%). About half felt that specialists were more efficient at providing follow-up than primary care physicians, but these same physicians recommended significantly longer and more expensive follow-up routines on average than others. Primary care physicians were felt to be important allies, especially in managing the psychosocial concerns of patients. CONCLUSIONS: Surveillance practices are generally in keeping with published recommendations. Most specialists feel that they should remain involved in follow-up, but this may result in increased resource utilization.  (+info)

A survey of intensity-modulated radiation therapy use in the United States. (7/250)

BACKGROUND: The objective of this study was to assess the current level of intensity-modulated radiation therapy (IMRT) use in the United States. METHODS: Three-hundred thirty-three randomly selected radiation oncologists were sent a 13-question survey regarding IMRT use. IMRT users were asked about the number of patients and sites treated, their reasons for adopting IMRT, and future plans for its use. Physicians who did not use IMRT were asked about their reasons for not using IMRT; whether they intended to adopt it in the future; and, if so, their reasons. RESULTS: One-hundred sixty-eight responses (50.5%) were received. Fifty-four respondents (32.1%) stated that they currently used IMRT. Most IMRT users (79.6%) had adopted IMRT since 2000. Academic physicians were more likely to use IMRT (P = 0.003) compared with private practitioners. The percent of physicians using IMRT in practices comprised of 1 physician, 2-4 physicians, or > 4 physicians were 15.4%, 28.4%, and 44.2%, respectively (P = 0.02). The most common sites treated were head and neck malignancies and genitourinary tumors. Of the 114 IMRT nonusers, 96.5% planned to use IMRT in the future, with 91.8% planning to use IMRT within 3 years. Among IMRT nonusers, the most common reason cited for not using IMRT was lack of necessary equipment. The most common reasons for adopting IMRT (users) or wanting to adopt IMRT (nonusers) were to improve delivery of conventional doses and to escalate dose. CONCLUSIONS: Approximately one-third of radiation oncologists in the United States use IMRT. However, this number appears to be growing rapidly. Efforts to ensure the safe and appropriate application of this new technology are warranted.  (+info)

Effect of education level on outcome of patients treated on Radiation Therapy Oncology Group Protocol 90-03. (8/250)

BACKGROUND: It has been hypothesized that people in lower socioeconomic groups have worse outcomes because they present with advanced-stage cancers or receive inadequate treatment. The authors investigated this hypothesis by using education level as a proxy for socioeconomic status in patients treated on Radiation Therapy Oncology Group (RTOG) Protocol 90-03. METHODS: RTOG 90-03 was a Phase III randomized trial investigating four different radiation fractionation schedules in the treatment of locally advanced head and neck carcinomas. Overall survival and locoregional control rates were analyzed by education level as measured by patient response on the demographic form at study entry. RESULTS: A significant difference was observed in the distribution of patients by education level between the standard fractionated radiation treatment arm and the hyperfractionated radiation treatment arm. More patients in the standard fractionated treatment arm had a higher education level (P = 0.018). Patients attending college had highly and significantly better overall survival and locoregional control than the other groups combined (P = 0.0056 and P = 0.025, respectively: from Cox proportional hazards models stratified by assigned treatment with educational level, T classification, N classification, Karnofsky performance status, primary site, and race). Multivariate analysis revealed that education level was significant for predicting both overall survival and locoregional control when comparing attended college/technical school compared with all other education levels. CONCLUSIONS: Patients attending college or technical school had improved overall survival and locoregional control. These differences cannot be explained by differences in tumor stage or treatment. Poorer overall health or lack of support systems contributing to these results needs to be investigated further.  (+info)

  • Dr. Song graduated with honors from the University of Chicago and received his medical degree from George Washington University where he also served as Chief Resident and was honored by the American Society for Therapeutic Radiology and Oncology as an ASTRO Research Fellow for 1995-96 by pursuing research in genetic radiotherapy. (usoncology.com)
  • Dr. Zimmerman has done extensive research in cancer treatment and was the recipient of an American Cancer Society Clinical Oncology Fellowship and a Radiological Society of North America Roentgen Resident/Fellow Research Award. (usoncology.com)
  • Halvorsen PH et al , AAPM Task Group 103 report on peer review in clinical radiation oncology physics. (iomp.org)
  • The multidisciplinary, international conference focuses on the challenging aspects and usage of advanced brain and spine radiation therapy for treatment of brain metastases, primary benign tumors, vascular malformations, spine tumors and how new clinical paradigms offer value-based medicine and patient-centered healthcare. (brainlab.com)
  • ACRO strives to ensure the highest quality care for radiation therapy patients and promote success in the practice of radiation oncology through education, responsible socioeconomic advocacy, and integration of science and technology into clinical practice. (alliancehealthcareservices-us.com)
  • The theme for this year's conference was "Controversies, Collaboration and Personalized Care in Radiation Oncology" and topics covered included clinical updates, the application of advanced techniques and technologies in care, economics and political issues, and clinical controversies. (alliancehealthcareservices-us.com)
  • We are building a collaborative environment and it all starts with having a huge reserve of clinical data at our fingertips," said Cynthia Kelsey Winker, RN, PhD, Senior Vice President Operations, Alliance Oncology. (alliancehealthcareservices-us.com)
  • To develop this standardized measurement system and metrics, Alliance Oncology created a multidisciplinary committee including clinical, operational, information technology and business development specialists. (alliancehealthcareservices-us.com)
  • As of summer 2013, CROF is offering a CARO-CROF Pamela Catton Summer Studentship in Radiation Oncology for medical students - this is an opportunity for medical students to gain clinical exposure to radiation oncology. (wildapricot.org)
  • Although there is a strong technical component to radiation oncology, it is first and foremost a clinical specialty that focuses on providing compassionate care for cancer patients through all parts of their disease journey, including diagnosis, treatment, and surveillance. (wildapricot.org)
  • Many graduating residents will pursue further training through a one or two-year clinical and/or research fellowship which allows for further specialization in a variety of areas, examples of which include treatment of specific disease sites, application of highly focused (stereotactic) radiation techniques including radiosurgery, and brachytherapy (placement of radioactive sources within body cavities for close treatment of tumours). (wildapricot.org)
  • The abstract will be presented at the "Big Data Workshop: Exploring Opportunities for Radiation Oncology in the Era of Big Data," co-sponsored by the American Society for Radiation Oncology (ASTRO), the National Cancer Institute (NCI) and the American Association of Physicists in Medicine (AAPM), August 13 - 14 in Bethesda, Md. and at the Association of Community Cancer Centers (ACCC) October 21 - 23 in Portland, Ore. (alliancehealthcareservices-us.com)
  • Newport Beach, Calif. - June 12, 2015 - Alliance HealthCare Services, Inc. (NASDAQ:AIQ), a leading national provider of outsourced healthcare services, announced today that Alliance Oncology exhibited a poster presentation at the American College of Radiation Oncology's 25th annual meeting from May 14 - 16 in Washington, D.C. (alliancehealthcareservices-us.com)
  • After completing two case studies, one that showed an increase in market share that contributed to a 12% revenue growth and one that decreased the time from patient scan to first treatment by 20%, the internally developed database was considered a success for Alliance Oncology. (alliancehealthcareservices-us.com)
  • Munich, February 18, 2016-On February 19th-20th, international experts in radiation oncology and neurosurgery will come together for the Sixth International Conference of the Novalis Circle in Munich sponsored by global medical technology leader, Brainlab. (brainlab.com)
  • Radiation oncology is a highly specialized field that many medical students will not be exposed to directly during their standard curriculum. (wildapricot.org)
  • The most common method is external beam radiation, which uses focused high powered x-rays generated by a machine called a linear accelerator (LINAC). (wildapricot.org)
  • P1 - Whole Body dosimeter - The P1 dosimeter provides a measurement of the deep (DDE) and shallow (SDE) radiation dose equivalent received by the whole body. (uiowa.edu)
  • U3 - Ring dosimeter - The U3 ring dosimeter provides a measurement of the extremity radiation dose equivalent received by the lower arm and hand. (uiowa.edu)
  • Wearing your dosimeters in accordance with the guidelines given above is required in order to obtain an accurate assessment of your radiation dose. (uiowa.edu)
  • Although traditionally thought of as an academic specialty, the opening of many new regionalized cancer centres has led to increasing numbers of radiation oncology working in "community" settings. (wildapricot.org)
  • Clinical and Translational Radiation Oncology is an international, open access journal which encompasses all aspects of clinical and translational radiation oncology research, particularly new developments in radiobiology, clinical interventions and treatments, data sciences, epidemiology, and oncopolicy. (elsevier.com)
  • Clinical and Translational Radiation Oncology uses an online manuscript submission and peer review process. (elsevier.com)
  • For any information regarding Clinical and Translational Radiation Oncology please contact [email protected] (elsevier.com)
  • The Division of Clinical and Radiation Oncology at the Stellenbosch University and the Tygerberg Hospital has a more than 25 year history of providing cancer care for a large section of the Western Cape community. (sun.ac.za)
  • A particular research focus is the development and evaluation of new technologies in radiation oncology, supportive cancer care, and shared doctor-patient decision making. (mcmaster.ca)
  • Dr. Schewe commented, "This new partnership with Alliance Oncology is a perfect approach to bring best in class private-practice cancer care and business strategy to a sophisticated community setting. (businesswire.com)
  • Innovations in technology and collaborative efforts within the global oncology community have created promising solutions for establishing quality cancer care in Africa and eradicating the massive disparities that currently exist. (medworm.com)
  • Smilow Radiation Oncology is a nationally recognized leader in the delivery and development of advanced radiation therapies to treat both common and rare cancers. (ynhh.org)
  • Smilow Radiation Oncology uses C-RAD ™ , a laser-based optical surface scanning system with functionality for 4-D CT reconstruction and gated imaging in a CT room. (ynhh.org)
  • IntelliSpace Radiation Oncology is the latest addition to Philips' renewed suite of radiation oncology systems and software. (philips.com)
  • First, the advances in radiation oncology in the decade since AAPM Report 13 (AAPM, 1984) necessitated a new document on quality assurance (QA). (aapm.org)
  • These programs also offer state-of-the-art equipment and training and utilize the same training infrastructure as the Karmanos Cancer Center residency program operated within the Gershenson Radiation Oncology Center. (karmanos.org)
  • The solution is being unveiled at the European Society for Radiation Oncology's (ESTRO) 38th Annual Meeting in Milan, Italy on Friday April 26, 2019. (philips.com)
  • In January 2019, Philips announced a collaboration with imaging solutions provider MIM Software Inc. (Cleveland, US), a company that provides practical imaging, automation, and data analysis solutions to radiation therapy clinics worldwide. (philips.com)
  • Over the last several decades, innovation in radiation oncology has been driven by technological advances in engineering and computer science that have allowed the more precise delivery of radiation. (moffitt.org)
  • Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology. (urotoday.com)
  • Radiation technique for prostate cancer has continuously evolved over the past several decades. (urotoday.com)
  • Alan Pollack, M.D., Ph.D., of the Sylvester Comprehensive Cancer Center at the University of Miami in Florida, and colleagues found that men with prostate cancer progression after prostate removal may benefit from extending radiation therapy to the pelvic lymph nodes along with a short course of hormone therapy. (drugs.com)